BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hanai T, Shiraki M, Watanabe S, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis. J Gastroenterol Hepatol 2019;34:1809-16. [PMID: 30779213 DOI: 10.1111/jgh.14635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Hiramine Y, Uto H, Mawatari S, Kanmura S, Imamura Y, Hiwaki T, Saishoji A, Kakihara A, Maenohara S, Tokushige K, Ido A. Efficacy of rifaximin, a poorly absorbed rifamycin antimicrobial agent, for hepatic encephalopathy in Japanese patients. Hepatol Res 2021;51:445-60. [PMID: 33533150 DOI: 10.1111/hepr.13622] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Miwa T, Hanai T, Nishimura K, Maeda T, Ogiso Y, Imai K, Suetsugu A, Takai K, Shiraki M, Shimizu M. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis. JPEN J Parenter Enteral Nutr 2021. [PMID: 34287991 DOI: 10.1002/jpen.2222] [Reference Citation Analysis]
3 Miwa T, Hanai T, Toshihide M, Ogiso Y, Imai K, Suetsugu A, Takai K, Shiraki M, Katsumura N, Shimizu M. Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy. Hepatol Res 2021;51:662-73. [PMID: 33242359 DOI: 10.1111/hepr.13601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Formentin C, Zarantonello L, Mangini C, Frigo AC, Montagnese S, Merkel C. Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE). Liver Int 2021;41:1070-82. [PMID: 33411388 DOI: 10.1111/liv.14785] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Akahane T, Yoshiji H. Role of serum albumin in hepatic encephalopathy. Hepatol Res 2021;51:353-4. [PMID: 33797845 DOI: 10.1111/hepr.13632] [Reference Citation Analysis]
6 Jiang TT, Liu XL, Jiang YY, Wang XB, Yang ZY. Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients. Evid Based Complement Alternat Med 2021;2021:6652858. [PMID: 34055016 DOI: 10.1155/2021/6652858] [Reference Citation Analysis]
7 Hanai T, Shiraki M, Nishimura K, Miwa T, Maeda T, Ogiso Y, Imai K, Suetsugu A, Takai K, Shimizu M. Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy. Hepatol Commun 2021;5:1518-26. [PMID: 34510827 DOI: 10.1002/hep4.1738] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nakanishi H, Hayakawa Y, Kubota Y, Kurosaki M, Osawa L, Inada K, Kirino S, Yamashita K, Sekiguchi S, Okada M, Wan W, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Tamaki N, Yasui Y, Noda T, Nakanishi K, Tsuchiya K, Itakura J, Takahashi Y, Izumi N. Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy. Sci Rep 2020;10:13566. [PMID: 32782294 DOI: 10.1038/s41598-020-70585-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]